BioSpace News Archive

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.

HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), a leading provider of health savings accounts (HSAs) and complementary consumer-directed benefits (“CDBs”), today announced its plans to release financial results for its third quarter of fiscal year 2020, following the close of regular stock market trading hours on Tuesday, December 3, 2019.

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York.

Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced that it has commenced an underwritten public offering of its common stock.

Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the launch of a public offering of units consisting of shares of its common stock (or pre-funded warrants) and warrants to purchase its common stock.

Revenues reached a record $1.5 million, up 101% over the third quarter of 2018 and up 28% over the second quarter of 2019

Phathom Pharmaceuticals, Inc. announced that David Socks, President and CEO, will present at the Jefferies 2019 London Healthcare Conference on Wednesday, November 20 at 10:40 a.m. GMT at the Waldorf Hilton, London.

Personalis, Inc., a leader in advanced genomics for cancer, reported financial results for the third quarter ended September 30, 2019.

Dicerna™ Pharmaceuticals, Inc. announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 11:30 a.m. EST in New York City.

Phio Pharmaceuticals Corp. announced that it has commenced a proposed public offering of shares of its common stock.